1     
CONCURRENT RESOLUTION URGING THE ISSUANCE OF

2     
FEDERAL GUIDELINES TO PROTECT CONSUMERS OF

3     
CANNABIDIOL PRODUCTS

4     
2020 GENERAL SESSION

5     
STATE OF UTAH

6     
Chief Sponsor: Curtis S. Bramble

7     
House Sponsor: Brad M. Daw

8     

9     LONG TITLE
10     General Description:
11          This concurrent resolution urges the issuance of product quality and safe consumption
12     guidelines for cannabidiol products.
13     Highlighted Provisions:
14          This resolution:
15          ▸     highlights the absence of federal guidelines addressing product quality and safe
16     consumption for cannabidiol products; and
17          ▸     urges Congress and the President of the United States to require the United States
18     Food and Drug Administration to issue product quality and safe consumption
19     guidelines for cannabidiol products.
20     Special Clauses:
21          None
22     

23     Be it resolved by the Legislature of the state of Utah, the Governor concurring therein:
24          WHEREAS, cannabidiol (CBD) is a chemical prevalent in marijuana and hemp;
25          WHEREAS, the federal Agriculture Improvement Act of 2018 removed hemp meaning
26     cannabis, or derivatives of cannabis, with a very low tetrahydrocannabinol (THC) content (not
27     more than 0.3% by dry weight) from the federal Controlled Substances Act definition of

28     marijuana;
29          WHEREAS, cannabidiol does not induce euphoria or reinforcing pleasure effects of
30     tetrahydrocannabinol found in marijuana;
31          WHEREAS, a 2018 World Health Organization report on cannabidiol concluded that
32     "there are no case reports of abuse or dependence relating to the use of pure CBD" and "there is
33     no evidence of recreational use of CBD or any public health-related problems associated with
34     the use of pure CBD";
35          WHEREAS, the 2018 World Health Organization report also cited a human study
36     (Martin-Santos, R., et al., Current Pharmaceutical Design, Volume 18, 2012) that
37     "administered 600 mg of CBD to healthy participants and detected no THC and trace
38     concentrations of THC metabolites";
39          WHEREAS, a substantial market for cannabidiol-formulated drinks, cosmetics, foods,
40     and other products has evolved, even in states that have not legalized medical or recreational
41     cannabis;
42          WHEREAS, cannabidiol-formulated products are sold in major retail chains in the
43     United States;
44          WHEREAS, within the past three years, more than 1,500 cannabidiol products have
45     come to market while the United States Food and Drug Administration has had no clear
46     approach to regulation, including balancing product access and consumer safety;
47          WHEREAS, the United States Food and Drug Administration states that food additives,
48     dietary supplements, and other products containing cannabidiol are illegal under federal law
49     and refuses to issue regulations or guidance to promote product quality and identify safe
50     consumption levels;
51          WHEREAS, the conflict between the United States Food and Drug Administration's
52     policy and the Agriculture Improvement Act of 2018 has led to a patchwork of cannabidiol
53     regulations by states that has failed to adequately protect consumers' health and increased the
54     complexity of the legal environment the cannabidiol product industry is required to navigate;
55          WHEREAS, the cannabidiol product industry is also hampered by the reticence of
56     banks, insurance companies, and merchant service companies to put their reputations at risk by
57     offering services to an industry threatened with regulatory action by the United States Food and
58     Drug Administration; and

59          WHEREAS, enactment of federal legislation requiring the United States Food and Drug
60     Administration to establish product quality and safe consumption guidelines for cannabidiol
61     would do much to promote the availability and safety of cannabidiol products and generate
62     significant interstate economic activity:
63          NOW, THEREFORE, BE IT RESOLVED that the Legislature of the state of Utah, the
64     Governor concurring therein, urges the United States Congress and the President of the United
65     States to act quickly to protect American consumers by requiring the United States Food and
66     Drug Administration to issue product quality and safe consumption guidelines for cannabidiol
67     products.
68          BE IT FURTHER RESOLVED that a copy of this resolution be sent to the President
69     and Vice President of the United States, the Majority Leader and Minority Leader of the United
70     States Senate, the Speaker and Minority Leader of the United States House of Representatives,
71     and each member of Utah's congressional delegation.